In non-small cell lung cancer, lncMEG3 was shown to competitively bind miR-21-5p, leading to a decrease in PTEN and thus inhibiting cell proliferation and metastasis [22]. This evidence concerns the gene PTEN and non-small cell lung carcinoma.